GB201416773D0 - Novel Methods For Including An Imune Response - Google Patents
Novel Methods For Including An Imune ResponseInfo
- Publication number
- GB201416773D0 GB201416773D0 GBGB1416773.8A GB201416773A GB201416773D0 GB 201416773 D0 GB201416773 D0 GB 201416773D0 GB 201416773 A GB201416773 A GB 201416773A GB 201416773 D0 GB201416773 D0 GB 201416773D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel methods
- imune
- imune response
- response
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1416773.8A GB201416773D0 (en) | 2014-09-23 | 2014-09-23 | Novel Methods For Including An Imune Response |
BE2015/5585A BE1022950B1 (en) | 2014-09-23 | 2015-09-21 | METHODS OF INDUCING AN IMMUNE RESPONSE |
PCT/EP2015/071562 WO2016046113A1 (en) | 2014-09-23 | 2015-09-21 | Novel methods for inducing an immune response |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1416773.8A GB201416773D0 (en) | 2014-09-23 | 2014-09-23 | Novel Methods For Including An Imune Response |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201416773D0 true GB201416773D0 (en) | 2014-11-05 |
Family
ID=51869339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1416773.8A Ceased GB201416773D0 (en) | 2014-09-23 | 2014-09-23 | Novel Methods For Including An Imune Response |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE1022950B1 (en) |
GB (1) | GB201416773D0 (en) |
WO (1) | WO2016046113A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109803676A (en) | 2016-04-12 | 2019-05-24 | 牛津大学创新有限公司 | Just exempt to target |
GB201608821D0 (en) | 2016-05-19 | 2016-07-06 | Isis Innovation | Vaccines |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0420634D0 (en) * | 2004-09-16 | 2004-10-20 | Glaxosmithkline Biolog Sa | Vaccines |
WO2009021931A1 (en) * | 2007-08-13 | 2009-02-19 | Glaxosmithkline Biologicals S.A. | Vaccines |
-
2014
- 2014-09-23 GB GBGB1416773.8A patent/GB201416773D0/en not_active Ceased
-
2015
- 2015-09-21 WO PCT/EP2015/071562 patent/WO2016046113A1/en active Application Filing
- 2015-09-21 BE BE2015/5585A patent/BE1022950B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BE1022950A1 (en) | 2016-10-21 |
BE1022950B1 (en) | 2016-10-21 |
WO2016046113A1 (en) | 2016-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201406151D0 (en) | Method | |
GB201409558D0 (en) | Method | |
GB201406155D0 (en) | Method | |
GB201408119D0 (en) | Method | |
GB201410262D0 (en) | Novel method | |
SG11201700172WA (en) | Method | |
ZA201704602B (en) | Dihydroindolizinone derivative | |
GB201403470D0 (en) | Method | |
ZA201605955B (en) | Novel methods for inducing an immune response | |
GB201410022D0 (en) | Method | |
IL248772A0 (en) | Cyclohexyl-pyridine derivative | |
GB201420832D0 (en) | Location method | |
GB201410101D0 (en) | Method | |
GB201409128D0 (en) | Method | |
GB201416773D0 (en) | Novel Methods For Including An Imune Response | |
GB201409234D0 (en) | Method | |
GB201409101D0 (en) | Method | |
GB201408649D0 (en) | Method | |
GB201401565D0 (en) | Novel method | |
GB201409127D0 (en) | Method | |
GB201409067D0 (en) | Method | |
GB201407971D0 (en) | Method | |
GB201407948D0 (en) | Method | |
GB201407815D0 (en) | Method | |
GB201407809D0 (en) | Method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |